CompanyNRIXNasdaqBrisbane, CA

Nurix Therapeutics, Inc.

Nurix Therapeutics develops targeted protein degradation medicines for cancer and autoimmune diseases.

SEC EDGAR ClinicalTrials.gov nurixtx.com

SCHEDULE 13GSep 23Latest SEC filing

Jul 9Latest story

July 2026

Nurix strikes $2.3 billion Roche pact for BTK degrader bexobrutideg

Jul 9Quarterly updatebexobrutideg Nurix Therapeutics, Inc.